OpenLB
Open Library of Bioscience
Advanced Search
Journal of cardiac surgery
Jun, 2022;37 (6): 1671-1673.

Cardiac surgery in nonagenarians: Rethinking operative strategies in the era of TAVR and TMVR.

Sara J Pereira
Author Information
  1. Sara J Pereira: Division of Cardiothoracic Surgery, University of Utah Health, Salt Lake City, Utah, USA.
PMID: 35288984 DOI: 10.1111/jocs.16399

Abstract

As growth of the elderly population continues to increase alongside improvements in percutaneous and minimally invasive interventions, cardiac surgeons question the role of high-risk surgery in treating these patients. TAVR has transformed the management of symptomatic severe aortic stenosis in elderly patients and has become standard therapy for patients greater than 80 years of age. With improvements in procedural risks and technical complications for both transcatheter valves and percutaneous interventions, should we rethink the operative strategies for octogenarians and nonagenarians, particularly as they apply to concurrent high-risk operations?

Keywords

TAVR TMVR cardiac surgery nonagenarians

References

  1. Davis JP, LaPar DJ, Crosby IK, et al. Nonagenarians undergoing cardiac surgery. J Card Surg. 2014;29(5):600-604.
  2. Caceres M, Cheng W, De Robertis M, et al. Survival and quality of life for nonagenarians after cardiac surgery. Ann Thor Surg. 2013;95(5):1598-1602.
  3. Bridges CR, Edwards FH, Peterson ED, Coombs LP, Ferguson TB. Cardiac surgery in nonagenarians and centenarians. J Am Coll Surg. 2003;197(3):347-356.
  4. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597-1607.
  5. Thourani VH, Jensen HA, Babaliaros V, et al. Outcomes in nonagenarians undergoing transcatheter aortic valve replacement in the PARTNER-I trial. Ann Thorac Surg. 2015;100(3):785-792.
  6. Arsalan M, Szerlip M, Vemulapalli S, et al. Should transcatheter aortic valve replacement be performed in nonagenarians? Insights from the STS/ACC TVT registry. J Am Coll Cardiol. 2016;67(12):1387-1395.
  7. Vlastra W, Chandrasekhar J, Vendrik J, et al. Transfemoral TAVR in nonagenarians: from the CENTER Collaboration. JACC Cardiovasc Interv. 2019;12(10):911-920.
  8. Mack MJ, Lindenfeld J, Abraham WT, et al. 3-year outcomes of transcatheter mitral valve repair in patients with heart failure. J Am Coll Cardiol. 2021;77(8):1029-1040.
  9. Sorajja P, Moat N, Badhwar V, et al. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients. J Am Coll Cardiol. 2019;73(11):1250-1260.
  10. Bapat V, Rajagopal V, Meduri C, et al. Early experience with new transcatheter mitral valve replacement. J Am Coll Cardiol. 2018;71(1):12-21.
  11. Muller DW, Sorajja P, Duncan A, et al. 2-year outcomes of transcatheter mitral valve replacement in patients with severe symptomatic mitral regurgitation. J Am Coll Cardiol. 2021;78(19):1847-1859.
  12. Yoon SH, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40(5):441-451.
  13. Mack M, Carroll JD, Thourani V, et al. Transcatheter mitral valve therapy in the United States: a report from the STS/ACC TVT registry. Ann Thorac Surg. 2022;113(1):337-65.
  14. Zoccai GB, Abbate A, D'Ascenzo F, et al. Percutaneous coronary intervention in nonagenarians: pros and cons. J Geriatr Cardiol. 2013;10:82-90.
  15. D'Ascenzo F, Bollati M, Clementi F, et al. Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol. 2013;167(2):575-84.
  16. Lichtman JH, Kapoor R, Wang Y, Radford MJ, Allen NB, Krumholz HM. Temporal trends of outcomes for nonagenarians undergoing coronary artery bypass grafting, 1993 to 1999. Am J Cardiol. 2007;100(11):1630-1634.
  17. Overtchouk P, Piazza N, Granada J, Soliman O, Prendergast B, Modine T. Advances in transcatheter mitral and tricuspid therapies. BMC Cardiovasc Disorders. 2020;20:1-10.
  18. Otowa K, Kohsaka S, Sawano M, et al. One-year outcome after percutaneous coronary intervention in nonagenarians: insights from the J-PCI OUTCOME registry. Am Heart J. 2022;246:105-116.
  19. Cepas-Guillen PL, Echarte-Morales J, Caldentey G, et al. Outcomes of nonagenarians with acute coronary syndrome. J Am Med Dir Assoc. 2022;23(1):81-86.
  20. Elsisy M, Schaff H, Crestanello J, et al. Outcomes of cardiac surgery in nonagenarians. J Card Surg. 2022. In press.

MeSH Term

Age Factors
Aged
Aged, 80 and over
Aortic Valve
Aortic Valve Stenosis
Humans
Nonagenarians
Risk Factors
Transcatheter Aortic Valve Replacement
Treatment Outcome
Journal Article
Article has an altmetric score of 1

Word Cloud

Created with Highcharts 10.0.0surgeryTAVRelderlyimprovementspercutaneousinterventionscardiachigh-riskpatientsoperativestrategiesnonagenariansTMVRgrowthpopulationcontinuesincreasealongsideminimallyinvasivesurgeonsquestionroletreatingtransformedmanagementsymptomaticsevereaorticstenosispatients andbecomestandardtherapygreater80yearsageproceduralriskstechnicalcomplicationstranscathetervalvesrethinkoctogenariansparticularlyapplyconcurrentoperations?​Cardiacnonagenarians:Rethinkingera

Similar Articles

Cited By